BrightEdge LLC, the American Cancer Society’s venture capital and impact investment arm, has released its annual report highlighting the impact its investments have had on cancer patients and their families. The report showcases the potential of the organization’s portfolio of 18 companies to improve the lives of over 1.5 million cancer patients. BrightEdge’s Cancer Impact Investing Framework measures the actual and potential impact of the investments it makes in accordance with the American Cancer Society’s mission to end cancer.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!